Life Sciences & Biotechnology
Renewal of access to structural biology facilities at ESRF, France
Virtual & in vitro screening of spiropyrrolidine derivatives & diverset core library small molecules to identify SARS-CoV-2 entry, fusion & protease inhibitors- An anti-COVID-19 drug discovery & development program
Understanding the role of B cells in cross presentation of plasmodium Liver-stage antigen(s) to CD8+ T cells
Understanding the molecular basis for the extreme differential level of expression of genes from human & animal Rota viruses in gene-transfected cells- Implications for improving the growth of human vaccine strains
Synthesis & anti-viral evaluation of newly designed nucleoside analogs beyond repurposing through revamping against emerging Coronavirus 2019 nCoV/SARS-CoV-2 by computational protocols
Pre-clinical evaluation of combination adjuvants for humoral & T cell immunity to respiratory Syncytial virus
Investigating SARS-CoV2 3-5 exonuclease (NSP14/ExoN) as therapeutic target for CoVID19
Inhibition of interaction between receptor binding domain of spike protein of SARS-CoV-2 & human ACE2 by protein mimic DNA [BT/TEMP10623/COVID/02/20]
Identifying therapeutic targets for blocking infection of highly pathogenic SARS-CoV-2 at an early stage- Developing novel screening assay with minimal bio-hazard risk
High-affinity binders against COVID-19 spike protein using display libraries
Pages
